相关实验视频
Updated: Jun 23, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
在患有多发性硬化症和认知问题的患者中,药物坚持的障碍和策略
Sarah Thomason1, Nima Moghaddam2, Nikos Evangelou3
1Trent Doctorate in Clinical Psychology, University of Nottingham, Nottingham, United Kingdom.
Multiple sclerosis and related disorders
|June 21, 2024
概括
多发性硬化症 (MS) 患者的认知问题显著影响了对疾病修饰治疗 (DMT) 的坚持,增加了诸如记忆问题和焦虑等障碍. 针对认知和情绪的干预措施可以改善DMT的坚持.
科学领域:
- 神经学 神经学
- 心理学 心理学 心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在多发性硬化症 (MS) 中,对疾病修饰治疗 (DMT) 的坚持是高度可变的.
- 虽然"忘记"是众所周知的障碍,但认知问题对坚持的影响尚未得到充分研究.
研究的目的:
- 确定MS患者的坚持障碍的患病率,重点关注认知障碍患者.
- 识别可以增强药物坚持的策略.
主要方法:
- 257名参与者通过英国MS Register和MS Society团体招募.
- 使用药物坚持调查问卷和感知缺陷调查问卷.
- 一部分参与者接受了定性访谈.
主要成果:
- 94%的人报告了坚持,但59%的人错过了剂量;25%的人有认知问题.
- 认知困难与障碍增加相关 (记忆,负面情绪,活动干扰).
- 认知,情绪和DMT的给药方法解释了17%的坚持差异;静脉注射治疗是预测因素. 焦虑调解了认知问题的影响在坚持.
结论:
- 解决认知和情绪问题的干预措施对于改善坚持至关重要.
- 尽量减少治疗负担和支持患者适应诊断是关键策略.
- 解决与副作用和治疗管理相关的焦虑是很重要的.
相关概念视频
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Barriers to Effective Communication II
3.6K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Barriers to Effective Communication I
8.8K
A communication barrier is any distortion or interruption during a conversation, resulting in miscommunication of the message. A good communicator should know these barriers and continuously check for the listener's understanding by obtaining feedback.
Communication barriers include the following:
Physiological barriers: They are limitations caused by a person's health condition or disability, such as hearing loss, poor eyesight, illness, or unconsciousness. An example to overcome this...
Communication barriers include the following:
Physiological barriers: They are limitations caused by a person's health condition or disability, such as hearing loss, poor eyesight, illness, or unconsciousness. An example to overcome this...
8.8K
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Factors Affecting Drug Distribution: Physiological Barriers
196
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
196

